Narimantas Evaldas Samalavičius, Vinsas Janušonis
Abstract
Purpose: the aim of the study was to prospectively evaluate patients who underwent colorectal surgery using Senhance® robotic platform in our center.
Methods: over a period of from November 2018 to August 2021 and since the adoption of Senhance® robotic surgery, 81 robotic colorectal procedures were performed. We performed the analysis of prospectively collected data. Perioperative, intraoperative and short-term postoperative data was assessed.
Results: From 81 patient who underwent colorectal resection using Senhance® robotic platform, 41 were female and 40 male, age range 23-92 years, on an average 62 years. Length of hospital stay as 3 to 48 days, on an average 7,4 days. Sixty-eight patients (83,9%) patients underwent operations for colorectal cancer (29 colon and 39 rectal), and the remaining thirteen patients were operated for benign diseases. The average operating time during the first 25 procedures was 3 hours and 38 minutes, ranging from 2 hours and 5 minutes to 6 hours and 20 minutes. During the last 25 procedures it was on an average 2 hours and 45 minutes, ranging from 1 hour and 20 minutes to 5 hours and 10 minutes. Amongst 68 patients with colorectal cancer, 16 (19,7%) were stage I, 16 (19,7%) stage II, 34 (41,9%) stage III and two (2,5%) were stage IV colorectal cancers. 39 (48,2%) operations were performed on the colon and 42 (51,8%) were different type of rectal surgeries. There were three (3.7%) conversions to open surgery, one of which was due to intraoperative complication – bleeding. 9 (11.1%) postoperative complications were recorded, of which three (3,7%) had to undergo interventions under general anaesthetic. No postoperative deaths occurred.
Conclusions: Our experience allows to conclude that colorectal surgery using the new Senhance® robotic platform is safe and feasible. Additional studies are mandatory to delineate the exact role of this type of robotic surgery in surgery of the colon and rectum.
Keyword(s): colorectal surgery; minimally invasive surgery; robotic surgery; Senhance® robotic platform.
DOI: 10.35988/sm-hs.2021.198
Full Text: PDF